Kenya imports more than 70% of its pharmaceutical products, making the country highly vulnerable to global supply chain disruptions, foreign exchange fluctuations, and soaring drug prices. This dependency on imported medicines poses a significant challenge to healthcare affordability and access, particularly in low-income and rural communities.